Patient-Specific Insulin-Resistance–Guided Infusion Improves Glycemic Control in Cardiac Surgery (original) (raw)
2010, The Annals of Thoracic Surgery
Background. Maintenance of appropriate capillary blood glucose in cardiovascular surgery patients has been associated with improved outcomes, including lower mortality. Interpatient variability in insulin resistance can make management difficult, leading to unexpected episodes of hypoglycemia and hyperglycemia. To improve postoperative glucose control at our institution, a patient-specific insulin-resistance-guided (IRG) protocol was developed. Methods. Prospective data were gathered on 100 consecutive cardiovascular surgery patients managed with our standard insulin infusion protocol and 100 patients managed using the IRG protocol. Clinical characteristics and glycemic indices were analyzed for the two groups. Primary endpoints included (1) percentage of time spent in the target range, (2) number of hypoglycemic and hyperglycemic episodes, (3) time to achievement of target blood glucose, and (4) the total daily dose of insulin required. Results. The IRG protocol resulted in significant improvements, including increased percentage of time spent in the normoglycemic range (82.5% versus 65.8%, p < 0.001), reduced rate of hypoglycemic episodes (0.12 versus 0.99, p < 0.01), reduced rate of hyperglycemic episodes (capillary blood glucose >126 mg/dL: 4.8 versus 8.2, p < 0.01), and a reduced time to the first measurement in the target range. Total daily dose of insulin was mildly increased, but failed to reach statistical significance (92.48 versus 82.64 units, p ؍ 0.32). Conclusions. Use of the IRG protocol led to improved glycemic indices while reducing episodes of hypoglycemia in both diabetic and nondiabetic patients. The ability to adjust a patient's insulin dosing based upon factors related to their insulin resistance results in improved blood glucose control and safety in cardiovascular surgery patients.
Related papers
Endocrine Practice, 2004
Objective: To describe the main findings of the Portland Diabetic Project, which elucidates the adverse relationship between hyperglycemia and outcomes of cardiac surgical procedures in patients with diabetes and delineates the protective effects of intravenous insulin therapy in reducing those adverse outcomes. Results: In this ongoing 17-year prospective, nonrandomized, interventional study of 4,864 patients with diabetes who underwent an openheart surgical procedure, we investigated the effects of hyperglycemia, and its subsequent reduction by continuous intravenous insulin (CII) therapy, on in hospital outcomes. Increasing blood glucose levels were found to be directly associated with increasing rates of death, deep sternal wound infections (DSWI), length of hospital stay (LOS), and hospital cost. In separate multivariate analyses, increasing hyperglycemia was found to be independently predictive of increasing mortality (P<0.0001), DSWI (P = 0.017), and LOS (P<0.002). Conversely, CII therapy, designed to achieve predetermined target blood glucose levels, independently reduced the risks of death and DSWI by 57% and 66%, respectively (P<0.0001 for both). Target blood glucose levels of less than 150 mg/dL and a 3day postoperative duration of CII therapy are both important variables that determine the effect of the CII therapy on improved outcomes. Coronary artery bypass graftingrelated mortality (2.5%) and DSWI rates (0.8%) in patients with diabetes were normalized to those of the nondiabetic population by the use of the Portland CII Protocol. Conclusion: Perioperative hyperglycemia in patients undergoing a cardiac surgical procedure affects biochemical and physiologic functions, which, in turn, adversely alter mortality, LOS, and infection rates. The Portland CII Protocol is a costefficient method that effectively eliminates hyperglycemia and reduces postoperative morbidity and mortality in patients with diabetes undergoing an openheart operation. CII protocols should be the standard care for glycometabolic control in all patients undergoing cardiac surgical procedures. 2 Abbreviations: AHA = American Heart Association; 3BG = 3day average postoperative blood glucose; CABG = coronary artery bypass grafting; CII = continuous intravenous insulin; DSWI deep sternal wound infection; ICU = intensivecare unit; LOS = length of hospital stay; OR = odds ratio; RR = relative risk; SQI = subcutaneous insulin.
BMC Anesthesiology
Background Intraoperative glycemic variability is associated with increased risks of mortality and morbidity and an increased incidence of hyperglycemia after cardiac surgery. Accordingly, clinicians tend to use a tight glucose control to maintain perioperative blood glucose levels and therefore the need to develop a less laborious automated glucose control system is important especially in diabetic patients at a higher risk of developing complications. Methods Patients, aged between 40 and 75 years old, undergoing open heart surgery were randomized to either an automated protocol (experimental) or to the conventional technique at our institution (control). Results We showed that the percentage of patients maintained between 7.8–10 mmol.l−1 was not statistically different between the two groups, however, through an additional analysis, we showed that the proportion of patients whose glucose levels maintained between a safety level of 6.7–10 mmol.l−1 was significantly higher in the e...
Rationale for glycemic control in cardiac surgical patients: The portland diabetic project
Insulin, 2006
This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology The author investigated the administration of continuous intravenous insulin (CII) in surgical patients with diabetes mellitus. This intervention was compared with subcutaneous (SC) insulin administration. Type of intervention Treatment. Economic study type Cost-effectiveness analysis. Study population The study population comprised patients with diabetes mellitus (including non-insulin and insulin-dependent diabetes mellitus) who were undergoing open-heart surgical procedures such as coronary artery bypass grafting (CABG) and isolated valve procedures. Setting The study setting was tertiary care. The economic study was undertaken in Portland, USA. Dates to which data relate The effectiveness and resource data were derived from patients enrolled in the study between 1987 and 2004. The price year was not stated. Source of effectiveness data The effectiveness data were derived from a single study. Link between effectiveness and cost data The costing study was undertaken prospectively on the same patient sample as that used in the effectiveness study.
Canadian Journal of Anesthesia/Journal canadien d'anesthésie, 2011
Purpose A safe and effective insulin infusion algorithm that achieves rigorous intraoperative glycemic control in noncardiac surgery has yet to be formally characterized and evaluated. We therefore report the validation of the DeLit Trial insulin infusion algorithm. Methods Patients scheduled for major noncardiac surgery were randomized to a target intraoperative blood glucose concentration of 4.4-6.1 mmoLÁL-1 (80-110 mgÁdL-1) intensive group or 10-11.1 mmoLÁL-1 (180-200 mgÁdL-1) conventional group. Glucose was managed with a dynamic intravenous insulin infusion algorithm. We compared the randomized groups on glucose time-weighted average (TWA), Preliminary results were presented at the Annual Meeting of the American Society of Anesthesiologists, October 2008.
Loading Preview
Sorry, preview is currently unavailable. You can download the paper by clicking the button above.